Common Contracts
3 similar Warrant Agreement contracts by Navidea Biopharmaceuticals, Inc., Cas Medical Systems Inc
WARRANT TO PURCHASE 114,213 SHARES OF COMMON STOCKWarrant Agreement • June 30th, 2014 • Cas Medical Systems Inc • Surgical & medical instruments & apparatus • New York
THIS CERTIFIES THAT, for value received, GE Capital Equity Investments, Inc. (“Holder”) is entitled to subscribe for and purchase ONE HUNDRED FOURTEEN THOUSAND TWO HUNDRED THIRTEEN (114,213) shares of fully paid and non-assessable Common Stock of CAS Medical Supplies, Inc., a Delaware corporation (“Company”), at the Warrant Price (as hereinafter defined), subject to the provisions and upon the terms and conditions hereinafter set forth. As used herein, the term “Common Stock” shall mean Company’s presently authorized common stock, $0.004 par value per share, and any stock into which such Common Stock may hereafter be converted or exchanged and the term “Warrant Shares” shall mean the shares of Common Stock which Holder may acquire pursuant to this Warrant and any other shares of stock into which such shares of Common Stock may hereafter be converted or exchanged. This warrant is being executed and delivered pursuant to the terms of a Loan and Security Agreement of even date among the C
WARRANT TO PURCHASE 135,542 SHARES OF COMMON STOCKWarrant Agreement • June 28th, 2013 • Navidea Biopharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • Delaware
THIS CERTIFIES THAT, for value received, MidCap Financial SBIC, LP (“Holder”) is entitled to subscribe for and purchase ONE HUNDRED THIRTY-FIVE THOUSAND FIVE HUNDRED FORTY-TWO (135,542) shares of fully paid and nonassessable shares of Common Stock of NAVIDEA BIOPHARMACEUTICALS, INC., a Delaware corporation (“Company”), at the Warrant Price (as hereinafter defined), subject to the provisions and upon the terms and conditions hereinafter set forth. As used herein, the term “Common Stock” shall mean Company’s presently authorized common stock, $0.001 par value per share, and any stock into which such Common Stock may hereafter be converted or exchanged and the term “Warrant Shares” shall mean the shares of Common Stock which Holder may acquire pursuant to this Warrant and any other shares of stock into which such shares of Common Stock may hereafter be converted or exchanged. This Warrant is being executed and delivered pursuant to the terms of a Loan and Security Agreement of even date a
WARRANT TO PURCHASE 165,663 SHARES OF COMMON STOCKWarrant Agreement • June 28th, 2013 • Navidea Biopharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • Delaware
THIS CERTIFIES THAT, for value received, GE Capital Equity Investments, Inc. (“Holder”) is entitled to subscribe for and purchase ONE HUNDRED SIXTY-FIVE THOUSAND SIX HUNDRED SIXTY-THREE (165,663) shares of fully paid and nonassessable shares of Common Stock of NAVIDEA BIOPHARMACEUTICALS, INC., a Delaware corporation (“Company”), at the Warrant Price (as hereinafter defined), subject to the provisions and upon the terms and conditions hereinafter set forth. As used herein, the term “Common Stock” shall mean Company’s presently authorized common stock, $0.001 par value per share, and any stock into which such Common Stock may hereafter be converted or exchanged and the term “Warrant Shares” shall mean the shares of Common Stock which Holder may acquire pursuant to this Warrant and any other shares of stock into which such shares of Common Stock may hereafter be converted or exchanged. This Warrant is being executed and delivered pursuant to the terms of a Loan and Security Agreement of e
